1.ALS as a Complex Neurodegenerative Disease
Motor neuron disease (MND), often referred to as amyotrophic lateral sclerosis (ALS), is a progressive and fatal neurodegenerative disorder. Those nerve cells relay signals from the brain and spinal cord to muscles. The connection between the motor neurons and muscles gets progressively weaker as the motor neurons are (together with their cell bodies in the spinal cord) being damaged.
ALS has various symptoms including muscle weakness, stiffness, twitching, difficulty walking, changes in speech/swallowing/breathing. ALS is also very challenging to treat, since it can progress in different ways for each person.
ALS is not a single biological failure. Neuroinflammation, oxidative stress, mitochondrial dysfunction, protein aggregation and homeostasis, immune imbalance in the local environment surrounding nervous cells might be involved. This complexity is why ALS care generally uses a multidisciplinary approach with a lot of oversight.
2.Caring for UC-MSCs as an Adjuvant
UC-MSCs (umbilical cord-derived mesenchymal stem cells) are gaining specific research interest in regenerative medicine on the basis of their signalling capacity. For ALS, the role of UC-MSCs is not necessarily to cure the disease or directly replace lost motor neurons.
Rather, UC-MSCs are investigated as a supportive cell signaling modality. This conjectural function is based upon the signals they secrete into the local tissue milieu. Such signals may comprise growth factors, cytokines, extracellular vesicles and other bioactive molecules that can modulate inflammation, immune response and cellular stress response.
First of all, let me make it perfectly clear that UC-MSCs do NOT cure ALS. They should never be classified as an infallible treatment for reversing ALS, halting degenerative changes, or even restoring any muscle function. Any explanation that is responsible should describe UC-MSCs as a research and adjunctive supportive option.
3.Supporting Inflammation Balance in ALS
One target zone being studied for ALS in stem cell therapy is inflammation balance. Neuroinflammation may continue to stress motor neurons in ALS. In certain cases, immune cells, which generally protect the body from disease and infection, become more active or dysregulated so as to create a toxic environment for nerve cells.
Here, we tested the immunomodulatory properties of UC-MSC. This suggests they might help direct immune activity in a balanced direction. This possible effect is potentially relevant to ALS care wherein chronic inflammation may provide intra-cellular pressure on already at-risk motor neurons.
But that does not mean UC-MSCs can cure ALS. The aim is much the more realistic: to support inflammatory balance and help provide a stable cellular milieu as part of comprehensive neurodegenerative care.
4.Enhancing Cellular Stress Response in ALS
Oxidative stress is another key component of ALS. Motor neurons are very cellular injury sensitive. Excessive oxidative stress could be behind additional damage to nerve cells and the deterioration of function.
Signaling related to UC-MSCs may bolster cellular pathways associated with the regulation of stress and resilience in tissues. This is part of the reason why UC-MSCs are appealing in possible use for neurodegenerative disease, researchers have said. The idea is not that UC-MSCs directly regenerate the nervous system but that their signaling might help bolster protective responses within the body.
This type of support, when offered to ALS patients, needs to be carefully understood. This may be part of an adjunctive strategy, but should not be touted as a sure cure for neurologic dysfunction.
Figure 1: UC-MSCs as Adjunctive Support for Oxidative Stress Regulation in ALS
5.Supporting Neurotrophic Signaling in ALS
Non-neurogenic functions: UC-MSCs are also likely to release neurotrophic support molecules. Neurotrophic factors are biological markers, or signals that support nerve cell survival, communication and maintenance. Given that motor neurons are affected in ALS, this part of regenerative medicine work is particularly relevant to ALS.
So technically, favorable signaling from UC-MSCs may support the beneficial setting for fragile nerve cells. Facilitating a healthier microenvironment (in what little ways one can) may be helpful in quieting stress signals and preserving residual function where possible.
Still, expectations must remain realistic. Being a progressive disorder, the response of ALS patients may differ by stage of disease and progression speed, respiratory condition as determined by lung function and other factors related to health or medical condition.
6.Supporting Multidisciplinary ALS Care
An appropriate program for delivery of UC-MSC stem cell therapy for ALS would not replace standard neurological care. ALS patients need a closer watch by the neurologist, medication monitoring, breathing evaluation and support with respiratory issues as well as nutrition assessment and help when it comes to swallowing in some instances along with rehabilitation via physical therapy occupational therapy and even have a plan for using mobility devices (if necessary), say medical professionals who work closely with ALS patients.
If UC-MSCs are to be considered, they ought to be placed within this larger whole system of care. Rather should the aim be one of support on its part instead of curative? Treatment Goals Can Then Be To Support Comfort, Quality-Of-Life, Inflammatory Balance, Cellular Resilience And Care Plan Support.
Patient screening is also essential. Prior to any cellular-based approach, doctors should consider diagnosis, progression rate, respiratory function (feasibility), infection risk/potential medications/blood tests and mobility status (realism).
In Conclusion: UC-MSCs for ALS Are Palliative and Not a Cure
UC-MSCs for ALS is an emerging field of regenerative/neurogenerative therapy. They are implicated in cellular signaling, immune modulation, inflamation regulation, oxidative stress assistance, neurotrophic signalling and microenviroment regulation.
ALS, however, continues to be a very complicated and dangerous disorder. The general UC-MSC context should be not read as a cure, a reversal method, or guaranteed treatment. The most conservative message is that UC-MSCs may provide complimentary biological signals in concert with existing ALS care.
UC-MSCs represent a potential addition to the care of select patients who are managed via an adapted medically-directed, protocolized and multidisciplinary treatment plan. The goal is not to promise a cure, but to approach the potential of restorative cellular signaling within reasonable expectations and humility befitting the complexity of ALS.